PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Saxena S et al. – The review explores the possibility of immunity and enzyme–based interventions as new therapeutic modalities and highlights the regulatory concerns on the prescription, usage and formulary development in the developed and developing world to keep the new chemical entities and therapeutic modalities viable to overcome antimicrobial resistance in S. aureus.

Related Articles

Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report
Pediatric Emergency Care, 10/29/09    Relevance Score: 69%

Staphylococcus aureus nasal carriage and its contributing factors
Future Microbiology, 11/05/09    Relevance Score: 68%

SpectraTM MRSA, A New Chromogenic Agar Medium to Screen for Methicillin-Resistant Staphylococcus aureus
Journal of Clinical Microbiology, 11/13/09    Relevance Score: 67%

Human Immune Proteome in Experimental Colonization with Staphylococcus aureus
Clinical and Vaccine Immunology, 11/11/09    Relevance Score: 67%

Efficacy of a swab transport system in maintaining long-term viability of Staphylococcus aureus
Diagnostic Microbiology and Infectious Disease, 10/22/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address